Trial Profile
The Effects of PF-04995274 on Emotional Processing in Treatment-resistant, Medicated, Depressed Patients
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 27 Jul 2022
Price :
$35
*
At a glance
- Drugs PF 4995274 (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- Acronyms RESTART
- 22 Jul 2022 Planned number of patients changed from 50 to 54.
- 22 Jul 2022 Planned End Date changed from 30 Apr 2020 to 26 Jul 2022.
- 22 Jul 2022 Planned primary completion date changed from 30 Apr 2020 to 26 Jul 2022.